Target-treatment and patients' selection: can we still neglect the timing of tissue collection?
De Pas
Tommaso
T
Putzu
Carlo
C
Pelosi
Giuseppe
G
Curigliano
Giuseppe
G
Noberasco
Cristina
C
Zampino
Giulia
G
Fazio
Nicola
N
Formica
Vincenzo
V
Spaggiari
Lorenzo
L
de Braud
Filippo
F
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy; D066246:ErbB Receptors / Q000096:biosynthesis / Q000145:classification*; D006801:Humans; D007150:Immunohistochemistry; D018579:Patient Selection; D015203:Reproducibility of Results
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab